Modulation of Curli Assembly and Pellicle Biofilm Formation by Chemical and Protein Chaperones  by Andersson, Emma K. et al.
Chemistry & Biology
ArticleModulation of Curli Assembly and Pellicle Biofilm
Formation by Chemical and Protein Chaperones
Emma K. Andersson,1,2 Christoffer Bengtsson,1,2 Margery L. Evans,3 Erik Chorell,1,2 Magnus Sellstedt,1,2
Anders E.G. Lindgren,2 David A. Hufnagel,3 Moumita Bhattacharya,4 Peter M. Tessier,4 Pernilla Wittung-Stafshede,2
Fredrik Almqvist,1,2,* and Matthew R. Chapman1,3,*
1Umea˚ Centre for Microbial Research
2Department of Chemistry
Umea˚ University, 901 87 Umea˚, Sweden
3Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI 48109-1048, USA
4Center for Biotechnology and Interdisciplinary Studies, Department of Chemical and Biological Engineering, Rensselaer Polytechnic
Institute, Troy, NY 12180, USA
*Correspondence: fredrik.almqvist@chem.umu.se (F.A.), chapmanm@umich.edu (M.R.C.)
http://dx.doi.org/10.1016/j.chembiol.2013.07.017SUMMARY
Enteric bacteria assemble functional amyloid fibers,
curli, on their surfaces that share structural and
biochemical properties with disease-associated
amyloids. Here, we test rationally designed 2-pyri-
done compounds for their ability to alter amyloid for-
mation of the major curli subunit CsgA. We identified
several compounds that discourage CsgA amyloid
formation and several compounds that accelerate
CsgA amyloid formation. The ability of inhibitor com-
pounds to stop growing CsgA fibers was compared
to the same property of the CsgA chaperone, CsgE.
CsgE blocked CsgA amyloid assembly and arrested
polymerization when added to actively polymerizing
fibers. Additionally, CsgE and the 2-pyridone inhibi-
tors prevented biofilm formation by Escherichia coli
at the air-liquid interface of a static culture. We
demonstrate that curli amyloid assembly and curli-
dependent biofilm formation can be modulated not
only by protein chaperones, but also by ‘‘chemical
chaperones.’’
INTRODUCTION
Amyloid proteins are commonly associated with neurodegenera-
tive disorders such asAlzheimer’s disease,Huntington’s disease,
and Parkinson’s disease (Chiti and Dobson, 2006). Seemingly
unrelated proteins of various size and primary amino acid
sequences can assemble into amyloids that share the same bio-
physical properties: amyloids are 4–12 nm wide fibers, have a
cross b sheet structure, are highly resistant to denaturation, and
bind amyloid-specific dyes such as Congo red and thioflavin T
(ThT) (Ban et al., 2003; Chapman et al., 2002). A growing number
of ‘‘functional’’ amyloids can be assembled by many cell types to
fulfill normal physiological processes, including regulation of
melanin synthesis, information transfer, or as structural materials
(Blanco et al., 2012; Fowler et al., 2006; Hammer et al., 2008).
Amyloids are commonly found as a protein component of the
extracellular matrix in bacterial biofilms. Bacteria within the bio-Chemistry & Biology 20, 1245–1film are protected from environmental strain, including disinfec-
tants and antibiotics, causing biofilms to be a major concern in
hospital and industrial settings. One of the best-studied func-
tional amyloids is curli, an extracellular fiber produced by
Escherichia coli and Salmonella species. Curli fibers are impor-
tant for adhesion to inert surfaces as well as host cells, biofilm
formation, and other community behaviors (Barnhart and
Chapman, 2006). Rugose bacterial colony biofilms, or red, dry,
and rough (rdar), develop on solid surfaces under conditions of
low osmolarity and low temperature (Ro¨mling, 2005). Rdar com-
munities have spatially distinct populations, as curliated bacteria
are limited to the biofilm-air interface where they contribute to
resistance to hydrogen peroxide and desiccation (DePas et al.,
2013; White et al., 2006). E. coli can also establish curli-depen-
dent biofilms, called pellicles, at liquid-air interface of static
cultures (Cegelski et al., 2009).
Curli biogenesis is a highly regulated process and requires the
products of two divergently transcribed operons (csgBAC and
csgDEFG) (Hammar et al., 1995). The major subunit protein of
curli is CsgA. CsgA is secreted to the cell surface as an unstruc-
tured protein and then templated into amyloid fibers by theminor
curli subunit CsgB (Bian and Normark, 1997; Hammar et al.,
1996, 2007, 2008; Shu et al., 2012; Wang et al., 2008). The
amyloid core of CsgA consists of five imperfect repeating units
(R1–R5). R1 and R5 are highly amyloidogenic, whereas R2, R3,
and R4 contain gatekeeper residues that reduce their ability to
form amyloids (Shewmaker et al., 2009; Wang et al., 2007,
2010). The secretion of CsgA and CsgB is dependent on
CsgG, which forms an oligomeric pore in the outer membrane
(Loferer et al., 1997; Robinson et al., 2006). CsgC is believed to
function cooperatively with CsgG, although CsgC is dispensable
for curli biogenesis and its function remains unknown (Taylor
et al., 2011). The chaperone-like CsgF assists the CsgB-CsgA
interaction and aids the nucleation of CsgA polymerization in vivo
(Nenninger et al., 2009). CsgE is a putative chaperone of CsgA
that also functions as a specificity factor in the periplasm
to facilitate efficient curli subunit secretion (Nenninger et al.,
2011; Robinson et al., 2006).
The use of functional amyloids as model systems to identify
general amyloid inhibitors has recently generated several prom-
ising leads (Andersson and Chapman, 2013; Cegelski et al.,
2009; Horvath et al., 2012; Romero et al., 2013). By screening254, October 24, 2013 ª2013 Elsevier Ltd All rights reserved 1245
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molecule called FN075 (compound 1) was identified as having
potent antiamyloid activities (Table 1; Figure 1) (Cegelski et al.,
2009). FN075 belongs to a class of 2-pyridones that was origi-
nally designed to mimic a C-terminal small peptide with several
positions in the central fragment available for substitutions (posi-
tions 2, 6, 7, and 8; Figure 1). The rigidity in the bicyclic scaffold
ensures that the 2-pyridones maintain a straight, peptide-like
conformation that mimics an extended beta strand (Cegelski
et al., 2009; Chorell et al., 2012). We have previously shown
that the peptidomimetic ring-fused 2-pyridone FN075 (com-
pound 1, Table 1; Figure 1) exerts a potent inhibitory effect on
CsgA amyloid formation by stabilizing an off-pathway oligomeric
form of the protein (Cegelski et al., 2009; Horvath et al., 2012).
In this work, we prepared a diverse library of substituted ring-
fused 2-pyridones where we varied the substitution pattern on
the central fragment to gain further structure activity relation-
ships (Figure 1). In addition, we also designed close analogs
of the known curli inhibitor, FN075 (herein referred to as ‘‘com-
pound 1’’) showing that small changes in the molecule have
drastic consequences for the effect on CsgA polymerization.
We also present small compounds that promote the formation
of curli. Moreover, we have found that the putative chaperone
CsgE is capable of not only preventing CsgA polymerization
but also preventing biofilm formation and arresting polymeriza-
tion of actively elongating fibers.
RESULTS
Compound Library and Initial Structure-Activity
Relationships
To further study structure-activity relationships between CsgA
and 2-pyridones, we initially tested a library of 65 compounds
(Table 1; Table S1 available online) with various substitution pat-
terns (varying positions 2, 6, 7, and 8 in Figure 1) for their ability to
inhibit CsgA polymerization. The compounds were tested in vitro
for their ability to modulate CsgA polymerization using the ThT
assay (Table 1; Table S1).Without compound, CsgA aggregation
into amyloid can be observed as a sigmoidal rise with distin-
guishable lag, growth, and stationary phases in ThT fluores-
cence as amyloid fibers are assembled (Naiki et al., 1989;
Wang et al., 2007). None of the 65 compounds from the initial
library resulted in increased inhibition of CsgA polymerization
as compared to compound 1, but several showed equivalent
activity (Table 1).
Because compound 1 had the best ability to inhibit CsgA
amyloid formation, we synthesized additional compounds
(40) using compound 1 as a starting point (Figure 1). Eight com-
pounds were synthesized with changes to the central fragment
of compound 1. The modifications we made to compound 1
included: extending the peptidomimetic backbone by intro-
ducing an amine (compound 7, Figure 1), adding rigidifying
tricyclic structures (compound 8, Figure 1), exchanging the
five-membered thiazolino group with a six-membered sultam
group (compounds 9 and 10, Figure 1), making a desulfurized
ring-opened analog (compound 11, Figure 1), and oxidizing the
sulfur to sulfoxide or sulfone (compounds 12 and 13, Figure 1)
(Horvath et al., 2013; Sellstedt and Almqvist, 2008). Compound
14 (Horvath et al., 2013) has both the extended peptidomimetic1246 Chemistry & Biology 20, 1245–1254, October 24, 2013 ª2013 Ebackbone and oxidized sulfur (Figure 1) (Sellstedt and Almqvist,
2009; Horvath et al., 2013; Berg et al., 2006). Finally, an addi-
tional three ‘‘control’’ compounds were synthesized to assess
the importance of position 3, 7, and 8 (Figure 1) Compound 3
lacks the trifluoro group at position 8 (Sellstedt and Almqvist,
2009), compound 5 lacks the carboxylic acid at position 3, and
compound 6 is missing the naphtyl group at position 7 (Table 1).
We also introduced acetylenes as a linker moiety at position 8
to see if compound activity would change with the 8-substituent
farther away from the central fragment. In addition, the acety-
lenes allowed us to expand the library further to synthesize
substituted triazoles at position 8. The synthesis of these com-
pounds was accomplished via copper (I) catalyzed azide alkyne
cycloadditions (CuAAC), which gave 24 additional compounds
(Table S2). The acetylene-substituted analogs were accessible
via a regioselective Sonogashira coupling to the iodo-bromo-
substituted analog 15 (Figure 2). This resulted in the R3-bromo
intermediates (compounds 16a–c) that were dehalogenated
and saponified to the desired carboxylic acid analogs (com-
pounds 18a, 18b, and 18c; Figure 2; Tables 1 and S2). The
bromo analogs were also hydrolyzed to evaluate the effect of a
R3-bromo substituent in combination with an acetylene spacer
in R1 (compounds 17a, 17b, and 17c in Figure 2; Tables 1 and
S2). These analogs were complemented with the brominated
compound 20 that lacks the acetylene in position 8 (Figure 2).
In summary, over 100 2-pyridone molecules were synthesized
and then screened for their ability to modulate the in vitro aggre-
gation of CsgA into amyloid using the ThT assay. Of the 106
tested compounds, 18 active and three inactive compounds
were selected for additional studies (Table 1; 17b, 17c, 18c,
and 20 in Figure 2).
Further Characterization of the CsgA Amyloid Inhibitors
The library of compounds was initially tested for modulation of
CsgA polymerization using the ThT assay (Figure 3A). To supple-
ment the ThT results, we used additional biophysical assays to
assess how the 21 selected compounds were affecting CsgA
aggregation. CsgA (5 mM) assembles into large SDS insoluble
amyloid polymers after overnight incubation; these aggregates
are large enough that they do not migrate into standard SDS
gels. Curli inhibitors, including compound 1, discourage CsgA
from adopting an SDS insoluble form, and CsgA runs into the
gel after overnight incubation (Figure 3B). SDS solubility after
overnight incubation with various compounds (50 mM) corre-
sponded well with the ThT results. Compounds 7, 8, 9, and 10
were potent inhibitors as determined by the ThT and maintained
CsgA in an SDS-soluble state (Figures 3A and 3B). Therefore,
extension of the peptide backbone in compounds 7 and 8 or
introduction of a sultam in compounds 9 and 10 increased the
ability of the compound to inhibit CsgA polymerization into amy-
loid (Table 1; Figures 3A and 3B).
We also probed the aggregation state of CsgA using grafted
amyloid-motif antibodies (gammabodies) that recognize CsgA
fibrils with conformational and sequence specificity (Ladiwala
et al., 2012; Perchiacca et al., 2012). The gammabody used here-
in contains the amyloidogenic R1 repeating unit domain of CsgA
(Wang et al., 2007) grafted into the third complementarity-
determining region of a single-domain (VH) antibody. The CsgA
R1 gammabody specifically recognizes polymerized CsgAlsevier Ltd All rights reserved
Table 1. Percent ThT Fluorescence Inhibition after Overnight Incubation at 50 mM Compound and 5 mM CsgA
ID Structure
Mean 
Inhibition
(%)
Maximum
(%)
Minimum
(%) ID Structure
Mean 
Inhibition
(%)
Maximum
(%)
Minimum
(%)
1 89 95 72 11 44 80 19
2 4 16 0 12 64 71 37
3 57 89 11 13 48 80 22
5 5 12 0 14 78 85 75
6 21 25 6 17b a
7 90 98 84 17c a
8 88 92 74 18c 81 89 57
9 92 97 89 20 80 87 67
10 96 97 87
Based on four individual experiments. See also Table S1.
aPromoting amyloid formation, shorter lag phase.
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Figure 1. Compounds Synthesized to
Analyze Central Fragment Alterations and
Substituents
With 1 as starting point, the peptidomimetic
backbone was extended by introducing an amine
in the pyridone ring resulting in compound 7. A
rigidified tricyclic structure, compound 8, was
included as well as analogs where the five-
membered thiazolino group had been exchanged
for six-membered sultams in compounds 9 and
10. Compound 11 is a desulfurized ring-opened
analog and compounds 12 and 13 are analogs
where the sulfur had been oxidized to the corre-
sponding sulfoxide or sulfone. Compound 14 has
both the extended peptidomimetic backbone and
oxidized sulfur.
See also Table S1.
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pounds found to be inhibitory by ThT analysis also showed
reduced gammabody binding (Figure 3C). A control blot detect-
ing all CsgA assured that the results were not due to differences
in the amount of deposited CsgA (Figure S1). Moreover, curli
fibers were undetectable by transmission electron microscopy
(TEM) when CsgA was incubated with inhibitory compounds
including compound 7, one of the most potent inhibitors (Fig-
ure 3D and data not shown).
CsgA Amyloid Accelerators
Although most of the compounds we analyzed inhibited or had
no affect on CsgA amyloid formation, compounds 17b and 17c
(brominated intermediates with an acetylene spacer) (Figure 2)
were found to accelerate CsgA polymerization into amyloid
(Table 1; Figure 4). When compound 17b or 17c was incubated
with CsgA, the lag phase was reduced in the presence of com-
pounds 17b or 17c from 2 hr for the DMSO control to 1 hr with
compound 17c and even shorter with compound 17b (Figure 4A).
Compounds 17b and 17c contain a bromine in position 6 and an
acetylene spacer in position 8, affording these compounds the
unique ability to accelerate CsgA polymerization and promoted
the conversion of CsgA into an SDS insoluble form (Figures 1,
3, 4A, and 4B; Table 1). SDS-insoluble CsgA was observed
as early as 8 hr when incubated with 17b or 17c (Figure 4C).
CsgA incubated in the presence of the accelerating compounds
was also recognized by the CsgA R1 gammabody, providing
additional evidence for amyloid formation (Figure 4D). Notably,
the acetylene spacer alone in position 8 (compound 18c) or1248 Chemistry & Biology 20, 1245–1254, October 24, 2013 ª2013 Elsevier Ltd All rights resbromine in position 6 with an aryl in posi-
tion 8 (without acetylene spacer, com-
pound 20) resulted in potent inhibition of
curli assembly (Figures 3, 4A, and 4B).
To test the hypothesis that CsgA still
assembles into morphologically similar
fibers in the presence of compounds
17b and 17c in vitro, we examined fibers
formed with or without accelerating com-
pounds by TEM. After 6 hr, CsgA formed
curli fibers that were loosely assembled
in bundles (Figure 4E). CsgA incubatedwith either of the two accelerating compounds, 17b or 17c, for
6 hr also formed abundant large assemblies of fibers that
appeared similar to those formed by CsgA (in the absence of
such compounds) (Figure 4E). This supports faster assembly of
ordered CsgA fibers in the presence of accelerating compounds.
2-Pyridones Modulate Curli-Dependent Biofilm
Formation
Small molecules, including D-amino acids and nor-spermidine,
can inhibit and disperse pellicle biofilms (Kolodkin-Gal et al.,
2010, 2012). The ability of certain 2-pyridones to inhibit CsgA
aggregation in vitro inspired us to test the ability of these com-
pounds to block pellicle biofilm formation by E. coli. Pellicle
biofilms form at the air liquid interface and are dependent on curli
fibers (Cegelski et al., 2009; Zhou et al., 2012b). Compound 1
inhibits CsgA amyloid formation in vitro and inhibits pellicle
biofilm formation (Figures 2A and 5B; Cegelski et al., 2009). Simi-
larly, compounds 7, 8, 18c, and 20, which inhibited CsgA fibrilli-
zation in vitro, could also inhibit pellicle formation (Figures 2A,
4A, 5A, 5B, and S2A). Interestingly, the accelerating compounds
17b and 17c did not appear to affect pellicle formation (Figures
5A and 5B). None of the compounds tested affected growth of
the bacteria (Figure S2B).
CsgE Modulates Pellicle Biofilm Formation
Similar to small molecule amyloid inhibitors, molecular chaper-
ones can also inhibit CsgA amyloid formation (Evans et al.,
2011). CsgE is a putative periplasmic chaperone and has been
shown to prevent CsgA self-assembly into amyloid fiberserved
Entry R Compound 
(yield %) 
Compound 
(yield %) 
Compound 
(yield %) 
1 cPr 16a (82) 17a (63) 18a (75) 
2 Ph 16b (82) 17b (67) 18b (83) 
3 mCF3Ph 16c (91)a 17c (75)b 18c (63) 
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Conditions a) Pd(PPh3)2Cl2, alkyne, CuI, TEA, DMF, rt or 50 oC b) LiOH in THF at  
rt or LiI in pyridine MWI 130 oC for 15 min c) Zn(s), AcOH, 100 oC d) NBS, MeCN, 
rt, 91% e) 1M LiOH, THF, rt, 89%.
aReaction was performed at 50 oC , bLiI in pyridine, MWI 130 oC for 15 min was used.
A
B
Figure 2. Synthesis of the Acetylene Spacer
Analogs and the Brominated Analog of 1
(A) Synthesis of acetylene spacer analogs 18a,
18b, and 18c. The intermediates 17a, 17b, and
17c, with bromine (Br) residues at position 6 were
also hydrolyzed and tested for biological activity.
(B) Bromination of 1 to obtain compound 20.
See also Table S2.
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whether the interaction between CsgE and CsgA fibers could
prevent further CsgA fiber elongation, we conducted an order
of addition experiment where CsgE was added at different times
after the start of CsgA polymerization. CsgAwas allowed to poly-
merize for 1, 2, 7, and 8 hr prior to the addition of CsgE. CsgE
arrested CsgA polymerization at the time of addition in all cases
(Figure 6A). The addition of CsgE to mature CsgA fibers did not
disassemble or destabilize fibers (data not shown). These results
are consistent with the idea that CsgE prevents fiber elongation,
possibly by sequestering soluble CsgA.
We then used surface plasmon resonance to test whether
CsgE directly interacts with CsgA amyloid fibers. Purified CsgA
was allowed to polymerize for 24 hr. Fibers were then sonicated
and immobilized on a GE Sensor-Chip and CsgE was injected
over the chip. A rapid increase in resonance units was observed
upon addition of CsgE indicating a direct interaction between
CsgE and CsgA fibers (Figure 6C, black line). Injection of a
mock purification of CsgE to control for possible copurified pro-
teins did not result in a large increase in resonance units (Fig-
ure 6C, gray line). CsgE also did not interact with BSA (data
not shown). Our SPR experiments using mature CsgA fibers
demonstrate that not only can CsgE stabilize CsgA monomers
but can also interact with CsgA fibers that may also inhibit mono-
mer addition to fiber ends.
The observation that peptidomimetic compounds could inhibit
pellicle biofilms (Figure 5) raised the question of whether proteins
naturally found in curli-dependent pellicle biofilms could exert a
similar effect. We therefore tested whether exogenous addition
of CsgE to pellicle biofilms could inhibit pellicle formation and
observed that the addition of purified CsgE could inhibit curli-
dependent biofilm formation (Figure 6D).Chemistry & Biology 20, 1245–1254, October 24, 2013 ªDISCUSSION
Because amyloid formation is readily
associated with human pathologies,
research on amyloid modulators has
been extensive (Ha¨rd and Lendel, 2012;
Kim et al., 2010; Ozudogru and Lippa,
2012; Sivanathan and Hochschild,
2012). Utilization of functional amyloid
systems to screen for small compounds
that affect amyloid formation has proven
utility (Horvath et al., 2012; Romero
et al., 2013; Sivanathan and Hochschild,
2012). The functional amyloid curli
assembled by E. coli provides a highly
tractable genetic system, straightfor-
ward and easily assessable in vivoassays, and good biochemical tools for measuring amyloid
formation.
We have used the curli system in E. coli to screen for amyloid
modulators that are based on the highly amendable 2-pyridone
backbone (Cegelski et al., 2009). We found improved inhibitors
that are derivatives of compound 1, which has a well-docu-
mented ability to inhibit curli amyloid formation (Figure 1) (Cegel-
ski et al., 2009; Horvath et al., 2012). Improved inhibitors were
obtained by extending the peptidomimetic backbone of com-
pound 1 by introducing an amine functionality in the pyridone
ring resulting in compound 7 (Horvath et al., 2013; Berg et al.,
2006) (Figures 1, 2A, and 2B; Table 1) and the rigidified tricyclic
analog (compound 8; Figures 1, 2A, and 2B; Table 1) (Horvath
et al., 2013). The desulfurized ring-opened analog (compound
11; Figure 1) (Horvath et al., 2013) and analogs that have an
oxidized sulfur (sulfoxide—compound 12 or sulfone—com-
pound 13) lost most of their inhibitory activity (Figures 3A and
3B; Table 1). Compound 14, which has both the extended pep-
tidomimetic backbone and oxidized sulfur (Figure 1; Horvath
et al., 2013) was able to modestly inhibit CsgA polymerization,
showing that the extension of the peptidomimetic backbone
is important and can compensate for the loss in activity by the
sulfoxide functionality (Figures 2A and 2B; Table 1).
The importance of the carboxylic acid for inhibition of curli for-
mation is clear, as the methyl ester compound 2 did not inhibit
CsgApolymerization in vitro or pellicle biofilm formation (Table 1).
Variations in this position were thus not further investigated
(Horvath et al., 2012). Removing the trifluoro methyl group from
compound 1 (to yield compound 3; Table 1) or introducing
a small aromatic group in position 7 (compound 6; Table 1)
reduced the ability to inhibit CsgA polymerization and allowed
CsgA to assemble into an SDS-insoluble aggregate (Table 1;2013 Elsevier Ltd All rights reserved 1249
Figure 3. In Vitro Effect of Inhibitory
Compounds on CsgA Polymerization
(A) ThT fluorescence of freshly purified 5 mM CsgA
with or without 50 mM compound. Reduction in
ThT fluorescence corresponds to inhibition of
CsgA polymerization.
(B) CsgA solubility after overnight incubation with
or without compound by SDS-PAGE. Compounds
that inhibit CsgA polymerization kept CsgA in a
soluble SDS-sensitive state.
(C) CsgA incubated overnight with compounds
was spotted onto a nitrocellulose membrane and
probed with a gammabody grafted with the CsgA
R1 sequence that detects CsgA amyloid structure.
(D) Transmission electron microscopy of freshly
purified CsgA incubated for 6 hr revealed abun-
dant fibers, whereas no curli fibers were detected
by when freshly purified CsgA was incubated for
6 hr with the inhibitor compound 7. Scale bars
represent 0.5 mM.
See also Figure S1.
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exchanging the five-membered thiazolino group for slightly
more flexible six-membered sultams (compounds 9 and 10; Fig-
ure 1) (Sellstedt and Almqvist, 2009), the inhibitory activity was
slightly improved (Figures 2A and 2B; Table 1), whereas the cor-
responding methyl ester compound 5 was inactive and further
proved the importance of the carboxylic acid (Figures 3A and
3B; Table 1).
The screening results were also clear regarding the substituent
in position 8. By exchanging position 8 from an aryl or hetero aryl
for a smaller cyclopropyl substituent the inhibitory effect was
completely lost (e.g., 21–31 in Table S1 and 82–84 in Table
S2). With this knowledge, we investigated if a spacer between
the central fragment and the aryl group in position 8 would
impact the activity. Hence, acetylene spacers were introduced
via Sonogashira couplings (Figure 2). The introduction of an
acetylene unit between the central fragment and the substituent
in position 8 resulted in compounds with great inhibitory activity,
at least as potent as compound 1. However, strikingly, two of the1250 Chemistry & Biology 20, 1245–1254, October 24, 2013 ª2013 Elsevier Ltd All rights ressynthesis intermediates (compounds 17b
and 17c) that have bromine at position 6
and an acetylene spacer accelerated
CsgA polymerization by reducing the lag
phase. These observations suggest that
17b and 17c may act either by directing
CsgA monomers into an amyloid nucleus
or by stabilizing the nucleus conforma-
tion. The accelerating compounds did
not appear to have an appreciable affect
on the elongation rate and CsgA polymer-
ization further supporting a role for 17b
and 17c primarily during the early oligo-
merization stages of amyloid formation.
The halide is crucial for the accelerating
activity, and future studies will evaluate
if other electron-withdrawing groups in
the same position can conserve or evenenhance this effect. We have previously described how a-synu-
clein forms on-pathway oligomers faster in the presence of com-
pound 1 (Horvath et al., 2012). It is possible that the accelerating
effects observed for compounds 17b and 17c on CsgA polymer-
ization follow the same mechanism. However, this is challenging
to test because the transition frommonomer to fiber is rapid, and
oligomers that may have formed are transient and difficult to
isolate and characterize.
The discrepancy between inhibitory effect for compounds 9
and 10 in in vitro assays such as the ThT assay and the in vivo
pellicle assay may be explained by differences in how the com-
pounds can access the in vivo environment where curli assembly
takes place around the cell. Furthermore, compounds may not
work in the in vivo assays because the media used for pellicle
growth or the incubation conditions may temper compound
activity.
CsgE inhibits CsgA amyloid assembly in vitro and is a putative
chaperone inside the bacterial cell, preventing amyloids from
forming until CsgA reaches the outside of the cell (Nenningererved
Figure 4. In Vitro Effect of Accelerating
Compounds on CsgA Polymerization
(A) ThT fluorescence of freshly purified 5 mM CsgA
with or without 50 mMcompound. The lag phase of
the fluorescence curve as a consequence of ThT
binding to polymerizing CsgA was shortened
when accelerating compounds 17b and 17c were
present.
(B) SDS-PAGE of CsgA incubated overnight with
or without compound. No soluble CsgA was de-
tected after incubation with accelerators 17b and
17c (lanes 4 and 5, respectively).
(C) SDS-PAGE of CsgA incubated for 8h with or
without compound. Incubation with the acceler-
ating compound 17c results in a SDS-insoluble
amyloid after 8 hr (lane 4) whereas pure CsgA is still
partly soluble (lane 2). In the presence of the
inhibitory compound 1, CsgA is soluble (lane 3).
(D) CsgA incubated overnight with compounds
was spotted onto a nitrocellulose membrane and
probed with the Tessier gammabody grafted with
the CsgA R1 sequence that detects CsgA amyloid
structure.
(E) Transmission electron microscopy of CsgA.
Negative staining of freshly purified CsgA incu-
bated for 6 hr (left). Freshly purified CsgA
incubated for 6h with accelerators 17b or 17c
appeared similar to CsgA alone. Fibers were not
detectable when CsgA was incubation with the
chemically similar, yet functionally inhibitory,
compound 20. Scale bars represent 0.5 mM.
See also Figure S1.
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gest that CsgE can disrupt on-going fiber formation. Extracel-
lular CsgE-mediated prevention of pellicle biofilm formation sug-
gests that this protein could play a role in the regulation of biofilm
development and maturation. Finally, the similarity of effects by
adding CsgE or chemical inhibitors to polymerizing CsgA reveals
that small molecule inhibitors can mimic the activity of protein
chaperones, thus acting as ‘‘chemical chaperones.’’
SIGNIFICANCE
The Earth’s microbial population exists predominately in
matrix-encased communities called biofilms. Bacterial bio-
films present a significant industrial and clinical challenge,
and new approaches are needed to combat biofilm forma-
tion. The extracellular matrix produced during biofilm
growth provides structural rigidity to the community as
well as protection from environmental insults. The major
proteinaceous components of E. coli and other enteric bac-
terial biofilm matrices are amyloid fibers, called ‘‘curli’’
(McCrate et al., 2013). Environmental biofilms have been
discovered to have an abundance of functional amyloids
(Larsen et al., 2007). Targeting formation of amyloid fibers
could be a means of preventing colonization, invasion, and
biofilm formation. 2-Pyridone compounds have been shownChemistry & Biology 20, 1245–1254, October 24, 2013 ªpreviously to possess antiamyloid and
antibiofilm activities and this inspired
us to further elaborate on the 2-pyri-done scaffold with added functional groups to identify addi-
tional antibiofilm compounds. During the characterization of
2-pyridones, we discovered compounds that had both anti-
amyloid and proamyloid characteristics. In addition to iden-
tifying 2-pyridone molecules with interesting biological
activities, we also provide insights into the dynamics of
curli-dependent biofilm formation by using both chemical
and protein chaperones to prevent in vivo amyloid formation
and pellicle biofilm growth. The curli-specific chaperone
CsgE was demonstrated to arrest curli aggregation
in vitro, and, strikingly, CsgE could also prevent pellicle bio-
film formation when added exogenously to cultures. Small
organic molecules that target bacterial amyloids and inhibit
or disrupt biofilm formation have great potential as new anti-
microbial therapeutics. These compounds are potentially
valuable tools to dissect the stages of amyloid formation,
amyloid inhibition by varying chemical species, and as mod-
ulators of amyloid-dependent biofilm formation.
EXPERIMENTAL PROCEDURES
Soluble CsgA Purification
C-terminal His6-tagged CsgA (Chapman et al., 2002) was, with somemodifica-
tions, purified as previously described (Cegelski et al., 2009). Briefly, NEB3016
slyD::kan pET11d-sec-csgA-6xhis cells were grown toOD600 0.9, inducedwith
IPTG, and incubated at 37C for 1 hr. Cells were pelleted by centrifugation and2013 Elsevier Ltd All rights reserved 1251
Figure 5. Inhibition of Pellicle Biofilm by Chemical Compounds
(A) Effect of the compounds at a concentration of 3 mM on the formation of curli-dependent pellicle biofilm, incubated at 26C for 48 hr. Compound 18c was the
most potent inhibitor.
(B) Effect of the compounds at a concentration of 50 mMon the formation of curli-dependent pellicle biofilm, incubated at 26C for 48 hr. Compounds 7, 18c, and
20 were correspondingly efficient in vitro.
See also Figure S2.
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Chemical and Protein Amyloid Chaperonesstored at 80C. Cells were lysed by incubation with stirring in an 8 M guani-
dine hydrochloride, 50 mM potassium phosphate solution pH 7.3 for 24 hr at
4C. The insoluble portion of the lysate was removed by centrifugation and
the remaining supernatant was incubated with NiNTA resin (Sigma-Aldrich)
for 1 hr at room temperature. The nickel affinity beads were washed with
50 mM potassium phosphate pH 7.3 and a 12.5 mM imidazole, 50 mM potas-
sium phosphate solution. His6-tagged CsgA was eluted with a 125 mM
imidazole, 50 mM potassium phosphate solution. Protein concentration was
determined by the BCA assay (Thermo Scientific).
CsgE Purification
CsgE-His was, with some modifications, expressed and purified as previously
described (Nenninger et al., 2011). Briefly, CsgE-His was expressed from
pNH27 (gene encoding cytoplasmic CsgE inserted into the NcoI-BamHI sites
of pET11d) in strain NEB 3016 with 100 mg/ml ampicillin. Cells were grown to
OD600 0.9 and induced for 1 hr with IPTG. Cells were pelleted by centrifugation
and resuspended in lysis buffer. Cells were lysed using a French press and
after centrifugation the supernatant was incubated with NiNTA resin (Sigma-
Aldrich) at 4C overnight. The nickel affinity beads were washed with lysis
buffer, followed by a 12.5 mM Imidazole, 50 mM potassium phosphate solu-
tion pH 7.3. His-tagged CsgE was eluted with a 250 mM Imidazole, 50 mM
potassium phosphate solution pH 7.3. The protein buffer was exchanged to
50 mM potassium phosphate, 200 mM sodium chloride pH 7.3 with 1 mM
PMSF on a Zeba Desalt Spin Column (Thermo Scientific).
In Vitro CsgA Polymerization Inhibition
Compound stock solutions were prepared at 20 mM in DMSO and diluted to
appropriate concentrations in 50 mM potassium phosphate buffer pH 7.3.
Purified soluble CsgA was diluted to 10 mM in potassium phosphate buffer.
Equimolar concentrations of CsgE and CsgA or equal volumes of compound
and CsgA were mixed in a 96-well black plate (Corning). Control experiments
were performed with 0.5% DMSO. Thioflavin T was added to a final concen-
tration of 20 mM and fluorescence was measured at 480 nm (excitation
440 nm) for 18 hr at 20C with agitation every 15 min on a Tecan Infinite 200i
to monitor amyloid formation.
CsgA Solubility
Freshly purified soluble CsgA and compounds were prepared and monitored
for amyloid formation as described above. After 18 hr incubation, 100 ml sam-
ples were collected and centrifuged at 16,1003 g for 20 min. The supernatant
fractions were transferred to fresh tubes and 30 ml aliquots weremixed with 43
SDS sample buffer (125 mM Tris pH 6.8, 10% 2-mercaptoethanol, 20% glyc-
erol, 6% sodium dodecyl sulfate, 0.02% bromophenol blue) and incubated at1252 Chemistry & Biology 20, 1245–1254, October 24, 2013 ª2013 E95C for 10 min. Samples were loaded on a 15% SDS-PAGE gel and analyzed
by PAGE Blue (Fermentas) staining. For the gel presented in Figure 5C, 8 hr
samples were not centrifuged and not boiled. In all other aspects, the proce-
dure was the same as described above.
Immunoblotting
Freshly purified soluble CsgA and compounds were prepared and monitored
for amyloid formation as described above. After 18 hr incubation, 100 ml sam-
ples were collected and centrifuged at 16,1003 g for 30 min. The pellets were
resuspended in 200 ml PBS (10mMPBS) and sonicated for three bursts on ice.
Each sample (2.5 ml) was dripped onto a nitrocellulose membrane (Bio-Rad).
The membrane was blocked for 2 hr with 10% milk in PBS at room tempera-
ture, rinsed with PBS, and thereafter incubated with FLAG-tagged R1 gamma-
body at 4C overnight. After rinsing with PBS, the membrane was incubated
with rabbit-anti FLAG antibody, rinsed again with PBS, and incubated with
HRP conjugated goat-anti rabbit antibody. Control blots were prepared in
the same way, incubated with anti- CsgA antibody produced in rabbit detect-
ing all CsgA as the primary antibody and after washing, incubated with HRP
conjugated goat-anti rabbit antibody. Signals were visualized using the Super
Signal West Dura Extended Duration Substrate (Thermo Scientific).
TEM and Immunogold
A JEM 1200 transmission electron microscope (Jeol) was used to visualize
the CsgA fibers. Samples were placed on formvar-coated nickel grids for
3 min, washed with deionized water two times, and stained with 1% sodium
silicotungstate for 1 min. Immunogold experiments were conducted on an
MC4100 csgE deletion mutant overexpressing CsgE from pTrc99A as
described previously (Epstein et al., 2009). The anti-CsgE antibody was diluted
1:5,000 prior to incubation with grids. No primary antibody control grids were
incubated with PBS.
Pellicle Biofilm
Appropriate volumes of compound stock solutions in DMSO or purified CsgE
were added to 2ml Luria broth no salt (LBNS) broth in sterile 24-well plates and
inoculated with 2 ml of an overnight culture of E. coli strain UTI89 grown in Luria
broth (LB). The plates were incubated statically at 26C, and after 48 hr of
growth wells were rinsed and stained with crystal violet.
Surface Plasmon Resonance
Interaction studies between CsgA amyloid fibers and CsgEwere conducted as
previously described with some modification (Zhou et al., 2012a). Forty micro-
liters of 1 mM CsgE or an equivalent volume of a mock purification (NEB3013
with pET11d) was injected over the sensor chip at 20 ml/min. The injectionlsevier Ltd All rights reserved
Figure 6. Effect of CsgE on CsgA Polymerization and Pellicle Formation
(A) Immuno-gold labeling of overexpressed CsgE. MC4100 csgEmutant cells with empty vector (left) or overexpressing CsgE (middle and right) were incubated
with CsgE antibody (left and middle) or buffer (right) followed by incubation with gold particle conjugated secondary antibody prior to uranyl acetate staining and
TEM. Scale bar represents 200 nm.
(B) CsgE interacts with CsgA fibers. Surface plasmon resonance sensograms of 1 mM purified CsgE (solid line) or a mock purification (dotted line) were injected
over immobilized sonicated CsgA fibers on a CM5 sensor chip. Flow of phosphate buffer was resumed after 120 s.
(C) CsgE added to freshly purified CsgA or CsgA incubated for 1 hr inhibits CsgA polymerization. CsgE added to CsgA incubated for 7 hr or 8 hr efficiently inhibits
further polymerization.
(D) SDS-PAGE after CsgA overnight incubation with or without equimolar concentration of the chaperone CsgE. No CsgA is left in solution when incubated alone
(lane 2) whereas CsgA incubated with CsgE (lane 3) was still in a soluble form.
(E) Extracellular addition of CsgE prevents formation of curli-dependent pellicle biofilm in a concentration-dependent manner.
Chemistry & Biology
Chemical and Protein Amyloid Chaperoneswas stopped at 120 s, and the flow of 50 mM potassium phosphate, 200 mM
sodium chloride buffer was resumed. The response was recorded in reso-
nance units.
Organic Compounds
Compound synthesis and characterization is described in the Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.chembiol.2013.07.017.
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